Fierce Biotech June 28, 2022
The radiology division of drugmaker Bayer is taking a step beyond its portfolio of devices for delivering contrast dyes for CT and MRI scans and moving into digital and artificial-intelligence-powered apps for medical imaging.
That includes the launch of a virtual marketplace that will house vendor-neutral programs for expediting patient reviews, automatically triaging serious cases and flagging scans of suspicious lesions.
Dubbed Calantic Digital Solutions, the new cloud-based platform aims to help automate various routine tasks across the radiologist’s workflow in an industry facing a shortage of trained specialists despite dramatic increases in the number of images produced—both from an aging population with heavier burdens of chronic conditions such as cardiovascular disease and cancer and from advances...